258 related articles for article (PubMed ID: 27089879)
1. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
2. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of class II trans-activator function by HIV-1 tat in mouse cells is independent of competition for binding to cyclin T1.
Mudhasani R; Fontes JD
Mol Immunol; 2002 Jan; 38(7):539-46. PubMed ID: 11750655
[TBL] [Abstract][Full Text] [Related]
5. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.
Forlani G; Tosi G; Turrini F; Poli G; Vicenzi E; Accolla RS
Front Immunol; 2017; 8():564. PubMed ID: 28555140
[TBL] [Abstract][Full Text] [Related]
6. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
7. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
Kanazawa S; Okamoto T; Peterlin BM
Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.
Tosi G; Forlani G; Andresen V; Turci M; Bertazzoni U; Franchini G; Poli G; Accolla RS
J Virol; 2011 Oct; 85(20):10719-29. PubMed ID: 21813598
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication.
Orlandi C; Forlani G; Tosi G; Accolla RS
J Transl Med; 2011 Jul; 9():106. PubMed ID: 21736733
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 replication is inhibited by a pseudo-substrate peptide that blocks Tat transactivation.
Okamoto H; Cujec TP; Peterlin BM; Okamoto T
Virology; 2000 May; 270(2):337-44. PubMed ID: 10792993
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Tosi G; Pilotti E; Mortara L; De Lerma Barbaro A; Casoli C; Accolla RS
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12861-6. PubMed ID: 16908858
[TBL] [Abstract][Full Text] [Related]
12. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
[TBL] [Abstract][Full Text] [Related]
13. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: activation of HIV-1 transcription by the MHC class II transactivator.
Saifuddin M; Roebuck KA; Chang Ch; Ting JP; Spear GT
J Immunol; 2000 Apr; 164(8):3941-5. PubMed ID: 10754282
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
17. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
20. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.
Xie B; Invernizzi CF; Richard S; Wainberg MA
J Virol; 2007 Apr; 81(8):4226-34. PubMed ID: 17267505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]